GlassScriptPhysician profile
Alberto X Ramos
NPI 1487788998
$551.12
in general payments reported to CMS, 2019-2025
17 companies · $80.12 in 2025
The $80.12 reported for 2025 was less than what a typical Hepatology provider received nationally (typical 2025 total: $981).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $93.49 · 2021: $22.38 · 2022: $106 · 2023: $67.21 · 2024: $63.50 · 2025: $80.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $98.83 | 2021-2023 | |
| Boston Scientific Corporation | $62.13 | 2022-2025 | Exalt Model D |
| Gilead Sciences, INC. | $59.70 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.04 | 2019-2020 | |
| Celgene Corporation | $41.83 | 2022-2023 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $35.07 | 2023-2025 | Gattex, Eohilia |
| Shionogi INC | $30.85 | 2019-2020 | |
| Eisai INC. | $23.92 | 2019 | |
| Alcresta Therapeutics, INC. | $23.30 | 2024 | Relizorb |
| Medtronic, INC. | $20.15 | 2024 | Endoflip |
| Vibrant Gastro, INC. | $20.05 | 2024 | Vibrant Starter Kit |
| Dynavax Technologies Corporation | $19.26 | 2020 | |
| Genzyme Corporation | $16.13 | 2023 | |
| Olympus America INC. | $16.05 | 2025 | Single Use Repositionable Clip |
| Intercept Pharmaceuticals, INC. | $13.80 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.79 | 2019 | |
| Intra-Sana Laboratories | $5.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Ramos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.